Both the nasal and IV forms of bumetanide had a variability in absorption of 27%, suggesting a more stable route of dosing ...

An experimental nasal spray has helped clear toxic protein buildups in the brains of mouse models of Alzheimer's. Its ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

A nasal spray would be a workaround for drug resistance seen with oral diuretics, with the potential to reduce hospital ...

A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as the standard oral and intravenous formulations of the medication, according ...

A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe ...

American Heart Association Scientific Sessions 2024, Late Breaking Science Abstract 4170722 - A study testing a new nasal ...

Doctors at North Kansas City Hospital found the same liquid in Timolol eye drops could be formed into a nasal spray.

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...

Corstasis to present pivotal trial data on Bumetanide Nasal Spray at AHA 2024, highlighting safety, and efficacy. #AHA2024.

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for several years after the initial diagnosis. A recent study by researchers at C ...

Researchers have developed a promising nasal spray therapy targeting neuroinflammation in Alzheimer’s disease, potentially ...